Open Access
| Issue |
Med Sci (Paris)
Volume 42, Number 3, Mars 2026
Chroniques génomiques
|
|
|---|---|---|
| Page(s) | 311 - 314 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/2026041 | |
| Published online | 20 mars 2026 | |
- Jordan B. Immunothérapie « CAR-T » : une autorisation qui fait date. Med Sci (Paris) 2017 ; 33 : 1003–6. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Messaoudi D, Perez F, Gouveia Z. Les nouvelles générations de cellules CAR-T. Med Sci (Paris) 2024 ; 40 : 848–57. [Google Scholar]
- Marshall A. In vivo CAR-Ts captivate big pharma. Nat Biotechnol 2025 ; 43 : 1893–6. [Google Scholar]
- Schett G, Mackensen A, Mougiakakos D. CAR T-cell therapy in autoimmune diseases. Lancet 2023 ; 402 : 2034–44. [Google Scholar]
- Bui TA, Mei H, Sang R, et al. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment. EBioMedicine 2024 ; 106 : 105266. [Google Scholar]
- Hunter TL, Bao Y, Zhang Y, et al. In vivo CAR T cell generation to treat cancer and autoimmune disease. Science 2025 ; 388 : 1311–7. [Google Scholar]
- Müller F, Taubmann J, Bucci L, et al. CD19 CAR T-cell therapy in autoimmune disease – a case series with follow-up. N Engl J Med 2024 ; 390 : 687–700. [CrossRef] [PubMed] [Google Scholar]
- Xin T, Cheng L, Zhou C, et al. In-vivo induced CAR-T cell for the potential breakthrough to overcome the barriers of current CAR-T cell therapy. Front Oncol 2022 : 12 : 809754. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.